Ruthenium-based photosensitizer TLD1411
Term · Oncology and biomedicine · MLC-T-ONC-016604
A ruthenium-based photosensitizer (PS), that can potentially be used for photodynamic therapy (PDT). Upon intratumoral administration, the ruthenium-based PS TLD1411 targets mitochondria in tumor cells. Upon PDT, TLD1411 produces singlet molecular oxygen (O2), and induces a reactive oxygen species (ROS)-mediated tumor cell apoptosis.
| Identifier | MLC-T-ONC-016604 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | PS TLD1411 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016604",
"term": "Ruthenium-based photosensitizer TLD1411",
"field": "Oncology and biomedicine",
"definition": "A ruthenium-based photosensitizer (PS), that can potentially be used for photodynamic therapy (PDT). Upon intratumoral administration, the ruthenium-based PS TLD1411 targets mitochondria in tumor cells. Upon PDT, TLD1411 produces singlet molecular oxygen (O2), and induces a reactive oxygen species (ROS)-mediated tumor cell apoptosis.",
"synonyms": [
"PS TLD1411"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/ruthenium-based-photosensitizer-tld1411/"
}
Record 14,610 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.